However, in chronic pathology such as diabetes, in which overexpression of the kinase is persistent, cardiac hypertrophy was observed [36] and is believed to be a result of its activating action on JNK and p38 MAPK pathways [35]. Here, MAPK1 is linked to diabetes mellitus.